These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 23042972)

  • 21. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting.
    Boyce JM; Havill NL; Otter JA; McDonald LC; Adams NM; Cooper T; Thompson A; Wiggs L; Killgore G; Tauman A; Noble-Wang J
    Infect Control Hosp Epidemiol; 2008 Aug; 29(8):723-9. PubMed ID: 18636950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores.
    Barbut F; Menuet D; Verachten M; Girou E
    Infect Control Hosp Epidemiol; 2009 Jun; 30(6):507-14. PubMed ID: 19379098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid Environmental Contamination With Candida auris and Multidrug-Resistant Bacterial Pathogens Near Colonized Patients.
    Sansom SE; Gussin GM; Schoeny M; Singh RD; Adil H; Bell P; Benson EC; Bittencourt CE; Black S; Del Mar Villanueva Guzman M; Froilan MC; Fukuda C; Barsegyan K; Gough E; Lyman M; Makhija J; Marron S; Mikhail L; Noble-Wang J; Pacilli M; Pedroza R; Saavedra R; Sexton DJ; Shimabukuro J; Thotapalli L; Zahn M; Huang SS; Hayden MK
    Clin Infect Dis; 2024 May; 78(5):1276-1284. PubMed ID: 38059527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of hospital-wide enhanced terminal cleaning of targeted patient rooms and its impact on endemic Clostridium difficile infection rates.
    Manian FA; Griesnauer S; Bryant A
    Am J Infect Control; 2013 Jun; 41(6):537-41. PubMed ID: 23219675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The novel application and effect of an ultraviolet light decontamination strategy on the healthcare acquisition of carbapenem-resistant Enterobacterales in a hospital setting.
    Lowman W; Etheredge HR; Gaylard P; Fabian J
    J Hosp Infect; 2022 Mar; 121():57-64. PubMed ID: 34915050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility of routinely using hydrogen peroxide vapor to decontaminate rooms in a busy United States hospital.
    Otter JA; Puchowicz M; Ryan D; Salkeld JA; Cooper TA; Havill NL; Tuozzo K; Boyce JM
    Infect Control Hosp Epidemiol; 2009 Jun; 30(6):574-7. PubMed ID: 19415969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing the spread of Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus on a burns unit through the intervention of an infection control bundle.
    Barbut F; Yezli S; Mimoun M; Pham J; Chaouat M; Otter JA
    Burns; 2013 May; 39(3):395-403. PubMed ID: 22884127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stopping Hospital Infections With Environmental Services (SHINE): A Cluster-randomized Trial of Intensive Monitoring Methods for Terminal Room Cleaning on Rates of Multidrug-resistant Organisms in the Intensive Care Unit.
    Ziegler MJ; Babcock HH; Welbel SF; Warren DK; Trick WE; Tolomeo P; Omorogbe J; Garcia D; Habrock-Bach T; Donceras O; Gaynes S; Cressman L; Burnham JP; Bilker W; Reddy SC; Pegues D; Lautenbach E; Kelly BJ; Fuchs B; Martin ND; Han JH
    Clin Infect Dis; 2022 Sep; 75(7):1217-1223. PubMed ID: 35100614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Environmental Contamination of Contact Precaution and Non-Contact Precaution Patient Rooms in Six Acute Care Facilities.
    Tanner WD; Leecaster MK; Zhang Y; Stratford KM; Mayer J; Visnovsky LD; Alhmidi H; Cadnum JL; Jencson AL; Koganti S; Bennett CP; Donskey CJ; Noble-Wang J; Reddy SC; Rose LJ; Watson L; Ide E; Wipperfurth T; Safdar N; Arasim M; Macke C; Roman P; Krein SL; Loc-Carrillo C; Samore MH
    Clin Infect Dis; 2021 Jan; 72(Suppl 1):S8-S16. PubMed ID: 33512527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and microbiological effect of pulsed xenon ultraviolet disinfection to reduce multidrug-resistant organisms in the intensive care unit in a Japanese hospital: a before-after study.
    Morikane K; Suzuki S; Yoshioka J; Yakuwa J; Nakane M; Nemoto K
    BMC Infect Dis; 2020 Jan; 20(1):82. PubMed ID: 31996170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and evaluation of the automated risk assessment system for multidrug-resistant organisms (autoRAS-MDRO).
    Hur EY; Jin YJ; Jin TX; Lee SM
    J Hosp Infect; 2018 Feb; 98(2):202-211. PubMed ID: 28807836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of bedside wipes in multi-patient rooms: a prospective, crossover trial evaluating infections and survival.
    Dadon M; Chedid K; Martin ET; Shaul I; Greiver O; Katz I; Saadon H; Alfaro M; Hod L; Shorbaje A; Braslavsky-Siag A; Moscovici S; Kaye KS; Marchaim D
    J Hosp Infect; 2023 Apr; 134():50-56. PubMed ID: 36754289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of hydrogen peroxide vapor for the inactivation of nosocomial pathogens on porous and nonporous surfaces.
    Lemmen S; Scheithauer S; Häfner H; Yezli S; Mohr M; Otter JA
    Am J Infect Control; 2015 Jan; 43(1):82-5. PubMed ID: 25564129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predominance of Lactobacillus spp. Among Patients Who Do Not Acquire Multidrug-Resistant Organisms.
    Araos R; Tai AK; Snyder GM; Blaser MJ; D'Agata EMC
    Clin Infect Dis; 2016 Oct; 63(7):937-943. PubMed ID: 27358350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the biological efficacy and rate of recontamination following hydrogen peroxide vapour decontamination.
    Otter JA; Cummins M; Ahmad F; van Tonder C; Drabu YJ
    J Hosp Infect; 2007 Oct; 67(2):182-8. PubMed ID: 17884250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrogen peroxide room disinfection--ready for prime time?
    Huttner BD; Harbarth S
    Crit Care; 2015 May; 19(1):216. PubMed ID: 25953384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal Assessment of Multidrug-Resistant Organisms in Newly Admitted Nursing Facility Patients: Implications for an Evolving Population.
    Mody L; Foxman B; Bradley S; McNamara S; Lansing B; Gibson K; Cassone M; Armbruster C; Mantey J; Min L
    Clin Infect Dis; 2018 Aug; 67(6):837-844. PubMed ID: 29635360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of ultraviolet devices and hydrogen peroxide systems for terminal room decontamination: Focus on clinical trials.
    Weber DJ; Rutala WA; Anderson DJ; Chen LF; Sickbert-Bennett EE; Boyce JM
    Am J Infect Control; 2016 May; 44(5 Suppl):e77-84. PubMed ID: 27131140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective cluster controlled crossover trial to compare the impact of an improved hydrogen peroxide disinfectant and a quaternary ammonium-based disinfectant on surface contamination and health care outcomes.
    Boyce JM; Guercia KA; Sullivan L; Havill NL; Fekieta R; Kozakiewicz J; Goffman D
    Am J Infect Control; 2017 Sep; 45(9):1006-1010. PubMed ID: 28431849
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.